BOSTON, Aug. 4, 2015 /PRNewswire-USNewswire/ -- Currently only seven percent of people diagnosed with pancreatic cancer in the United States will survive more than five years. When Bostonian Ed Quinn was diagnosed with this disease, he was told he had no more than a year to live. After two and half years, 37 chemo treatments, 25 sessions of radiation and half a dozen other medical procedures, Ed continues to fight with tenacity and courage while doing all he can to lend his voice on behalf of other pancreatic cancer patients.
For the third year, Ed and his loved ones will #WageHope alongside nearly 2,000 people who have joined in the movement to change the future for this disease and double pancreatic cancer survival by 2020 at PurpleStride Boston. The awareness walk will take place on Sunday, August 16 and will raise awareness and funds to support the mission of the Pancreatic Cancer Action Network to advance research, support patients and create hope. "I am a pancreatic cancer survivor. I like to say that as often as I can and will keep striding until more people diagnosed with this disease can do the same," said Quinn.
To register visit purplestride.org.
The 1- or 3-mile family-friendly walk, taking place at Boston Common, will begin at 10:45 a.m. with registration opening at 10:00 a.m. Early registration on-line is $25 for adults and $10 for children between the ages of 3-12; on-site registration is $30 for adults and $15 for children. Survivors attend the event free of cost. PurpleStride Boston is possible because of thousands of participants throughout the years and the generous support of numerous sponsors, including Regional Gold Sponsors Halozyme Therapeutics and NewLink Genetics; Gold Sponsors Momenta Pharmaceuticals, EMD Serono, and WCVB; and National Silver Sponsors, Celgene and AbbVie.
"PurpleStride Boston is an uplifting day meant to create hope and encouragement for people who have been affected by pancreatic cancer," said Michele Wood, spokesperson for the Boston Affiliate of Pancreatic Cancer Action Network. "Participants will come together not only as a tribute to those that have lost their battle to this disease, but to honor and inspire those in the community, like Ed, who are bravely facing pancreatic cancer today."
This year, it is estimated 48,960 Americans will be diagnosed with pancreatic cancer and approximately 40,560 will die from the disease. A study by the Pancreatic Cancer Action Network, published in the journal Cancer Research, predicts that by 2020 pancreatic cancer will surpass breast and colorectal cancer to become the second leading cause of cancer-related death in the United States.
To learn more about the Pancreatic Cancer Action Network and the Boston Affiliate, please visit pancan.org.
About the Pancreatic Cancer Action Network
The Pancreatic Cancer Action Network is the national organization creating hope in a comprehensive way through research, patient support, community outreach and advocacy for a cure. The organization is leading the way to change outcomes for people diagnosed with this devastating disease through a bold initiative — The Vision of Progress: Double the Survival for Pancreatic Cancer by 2020. Together, we can know, fight and end pancreatic cancer by intensifying our efforts to heighten awareness, raise funds for comprehensive private research, and advocate for dedicated federal research to advance early diagnostics, better treatments and increase chances of survival.
Public Relations Manager
Pancreatic Cancer Action Network
Media Relations Chair
Pancreatic Cancer Action Network – Boston Affiliate
Direct: (978) 836-6376
SOURCE Pancreatic Cancer Action Network